Furthermore, the anti-interleukin-6 drug tocilizumab (Actemra) appeared more effective than other biologics such as tumor necrosis factor (TNF) inhibitors, they reported in the Annals of the ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.